Tag: Cancer Research

Innovation Forum

Interview with Neobe Therapeutics

Narges Sheikhansari: Hello and thank you both for being here today. I’ll start with my first question, please tell us about your team. What are your backgrounds and your founding story?  Pedro Correa de Sampaio [CEO, Neobe Therapeutics]: So, I’ve been working in the tumour microenvironment area for many years, always as an academic. Considering that one ofaaa

Read more
Innovation Forum

Interview with Isaac Johnson, CEO of Verinnogen

Narges Sheikhansari: Thanks for accepting our invitation to this interview. It’s great to have you here today. So, the first question is about your team. What are your backgrounds and what is your founding story?  Isaac Johnson: That’s a really great place to start. I think for us, it all started back, in 2019. So, back thenaaa

Read more
Innovation Forum

Clinical Innovation & Partnering Congress

Taking place on the 8-9th March 2017 in partnership with the Innovation Forum and NIHR, and developed by a cohort of thought leaders at J&J and Lilly this year’s congress marks the 10th anniversary of the world series. The Clinical Innovation and Partnering Congress will be showcasing disruptive tech, game-changing innovation, novel partnering strategies toaaa

Read more
Innovation Forum

Clinical Innovation & Partnering Congress

Taking place on the 8-9th March 2017 in partnership with the Innovation Forum and NIHR, and developed by a cohort of thought leaders at J&J and Lilly this year’s congress marks the 10th anniversary of the world series. The Clinical Innovation and Partnering Congress will be showcasing disruptive tech, game-changing innovation, novel partnering strategies toaaa

Read more
Innovation Forum
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.